1204875-03-5 Usage
Uses
Used in Medicinal Chemistry:
5-Benzyl-5-azaspiro[2.4]heptane is utilized as a structural component in the design and synthesis of novel pharmaceutical agents, leveraging its unique spirocyclic ring system to explore new avenues in drug discovery and development.
Used in Drug Discovery:
As a compound with potential biological activity, 5-Benzyl-5-azaspiro[2.4]heptane serves as a candidate for further research in drug discovery, where its specific interactions with biological targets can be investigated for therapeutic applications.
Used in Chemical Research:
5-Benzyl-5-azaspiro[2.4]heptane is employed as a subject of study in chemical research to understand its reactivity, stability, and potential to form new compounds or complexes, which could be beneficial in various chemical and pharmaceutical processes.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Benzyl-5-azaspiro[2.4]heptane is used as a starting material or intermediate in the synthesis of complex organic molecules with potential medicinal properties, contributing to the development of new drugs and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 1204875-03-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,4,8,7 and 5 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1204875-03:
(9*1)+(8*2)+(7*0)+(6*4)+(5*8)+(4*7)+(3*5)+(2*0)+(1*3)=135
135 % 10 = 5
So 1204875-03-5 is a valid CAS Registry Number.
1204875-03-5Relevant academic research and scientific papers
Spiro compounds and methods of use
-
Page/Page column 9, (2010/11/27)
The present invention relates to spiro compounds of formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states such as cancers associated with protein tyrosine kinases, especially epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF), to their method of use as medicaments and to their method of use in the manufacture of medicaments for use in the production of inhibition of tyrosine kinase reducing effects in warm-blooded animals such as humans.
